Observations placeholder
Exjade
Identifier
018982
Type of Spiritual Experience
Background
A description of the experience
Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer...) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.
It was approved by the United States Food and Drug Administration (FDA) in November 2005] According to FDA (May 2007), renal failure and cytopenias have been reported in patients receiving deferasirox oral suspension tablets. It is approved in the European Union by the European Medicines Agency (EMA) for children 6 years and older for chronic iron overload from repeated blood transfusions.
On Jan, 03, 2017 24,441 people reported to have side effects when taking Exjade.
Among them, 43 people (0.18%) have Hallucination
Time on Exjade when people have Hallucination:
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination46.15%53.85%0.00%0.00%0.00%0.00%0.00%
On Nov, 21, 2015: 18,158 people reported to have side effects when taking Exjade. Among them, 4,165 people (22.94%) have Death.
Time on Exjade when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death15.95%34.59%19.35%15.41%13.80%0.90%0.00%